menu_open Columnists
Jeffrey Skolnick

Jeffrey Skolnick

The Conversation

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

AI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseases

AI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseases

AI is reshaping biomedical research and drug discovery and delivery. But challenges still exist.

07.04.2026 6

The Conversation

Jeffrey skolnick